ArticleTrials2024

Obesity Treatments to Improve Type 1 Diabetes (OTID): a randomized controlled trial of the combination of glucagon-like peptide 1 analogues and sodium-glucose cotransporter 2 inhibitors-protocol for Obesity Treatments to Improve Type 1 Diabetes (the OTID trial).

Ebaa Al-Ozairi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.